Menu

Search

  |   Technology
Become a contributor

Menu

  |   Technology

Search

Carbon monoxide exposure in homes is a risk – here's how to protect yourself

Samsung Galaxy Tab S4 Release Date, Specs: LTE-Enabled Tablet Appears in Chinese Regulatory Filing; Other Features Leaked

Bees join an elite group of species that understands the concept of zero as a number

Bacteria Could Be the Key To Breathing on Mars, Study Says

Eyebrows Were Crucial For Human Survival, Study Says

Magnets Could Be the Key to Better Wine, Study Finds

Real, Live Mad Scientists Send Electric Shocks to People's Brains to Make Them Less Violent

‘Dragon Ball Xenoverse 2’ DLC 7 Update: Kefla Added to Roster in Time for Epic Son Gohan Fight

US health care companies begin exploring blockchain technologies

Black swans and other deviations: like evolution, all scientific theories are a work in progress

‘Fallout 76’ Release Date, Features: Director Todd Howard Insists It’s Not ‘Survival’ and They Care About Player Progression

Huawei Nova 3i News and Updates: Best Budget Mobile Gaming Phone Thanks to New Kirin 710 Processor?

iOS 12 News and Updates: Public Beta 3 Has Been Released; Expect Crashes and Erased Data

Tech innovators start to see old-fashioned benefits of collective bargaining

Ethereum Can Take Over Bitcoin’s Number One Position, Crypto Observers Predict

'Elder Scrolls 6' Release Updates and Features: Bethesda Committed to the Single-Player Experience

‘Call of Duty: Black Ops 4’ Release Date, Features: Time Travel, Undead Tiger and Medieval Warriors Included in Zombies Mode

Automation Takes Over Stem Cell Manufacturing Too, FDA Approves

Stem Cell Illustration.PublicDomainPictures/Pixabay

Tuesday, January 16, 2018 4:57 AM UTC
0
comments

When discussing stem cell research, most people would likely bring up scientists harvesting stem cells from living tissue. While this is certainly true, there is now a new method that would allow researchers to manufacture stem cells so that they have much more of it to work with. The U.S. Food and Drug Administration (FDA) recently approved the process employed by the Mayo Clinic, which actually automates the process.

In a press release, the Mayo Clinic describes both the process and implications of the FDA approval to stem cell research. Apparently, this allows the researchers to take the bone marrow of a donor and then produce a much higher quantity of stem cells that will then be used to advance research in regenerative medicine.

According to the medical director of Transfusion Medicine and the Human Cell Therapy Laboratory, Abba Zubair, this process is a huge boon for cases where the patient’s own stem cells are not enough to allow for treatment. These cases can often be a problem, mostly because harvesting stem cells is not exactly that easy.

“This may make treatments possible in cases where the patient’s own cells are not viable as therapy,” Dr. Zubair said. “In addition, because the cells can be produced in days instead of months, it may also make treatments available on short notice when they’re needed for acute care.”

As Futurism notes, stem cell research has already proven promising in a variety of treatment cases, addressing everything from arthritis to paralysis. By cranking up production of stem cells via an automated production method, not only will researchers have significantly more batches to work with, patients won’t have to wait for months to be treated.

On a side note, this process also highlights the huge advantages to automating the manufacturing process in the field of research and medicine. In these areas, robots are just taking over, and that might be for the best.

Editor's Picks

Scientists Wants To Use Poison As Male Birth Control

How the digitalisation of everything is making us more lonely

New App Equipped With AI Could Help Treat Depression

How neoliberalism is damaging your mental health

Why ignoring mental health needs of young Syrian refugees could harm us all

Researchers Create Aluminum That’s As Strong As Stainless Steel

Automation To Hit Women In the Workforce Harder Than Men, Study Finds

Looking at the universe through very different 'eyes'

Automation Takes Over Stem Cell Manufacturing Too, FDA Approves

Eating weed gummies at work? Maybe not until 2028.

What are antioxidants? And are they truly good for us?

Are you a "cyberloafer"? Why internet procrastination is making life easier for hackers
  • ET PRO
  • Market Data

Market-moving news and views, 24 hours a day >

2018-07-20 20:30:38
0m
S&P SAYS BELIEVES SHAPE, TIMING OF ADDITIONAL SANCTIONS ON RUSSIA LIKELY TO STEM FROM RUSSIA'S FOREIGN POLICY ACTIONS, U.S. DOMESTIC POLITICAL DEBATE
2018-07-20 20:30:33
0m
S&P SAYS "IN OUR VIEW, RUSSIA SUFFERS FROM WEAK CHECKS AND BALANCES BETWEEN INSTITUTIONS AND HIGH CENTRALIZATION OF POWER"
2018-07-20 20:30:20
0m
S&P SAYS BELIEVE THAT IMPLEMENTING STRUCTURAL REFORM PROPOSALS FOLLOWING THE PRESIDENTIAL ELECTION WILL BE CHALLENGING FOR RUSSIA
2018-07-20 20:30:11
0m
S&P SAYS RUSSIA'S GROWTH IS LIKELY TO REMAIN BELOW THAT OF PEERS, NOT LEAST DUE TO UNCERTAINTY CREATED BY INTERNATIONAL SANCTIONS
2018-07-20 20:30:05
0m
S&P SAYS RUSSIA'S EXTERNAL, PUBLIC BALANCE SHEETS WITH PRUDENT FISCAL FRAMEWORK, SHOULD ENABLE IT TO ABSORB SHOCKS FROM POSSIBLE NEW INTERNATIONAL SANCTIONS
2018-07-20 20:29:57
0m
S&P SAYS EXPECT KUWAIT'S FOREIGN POLICY TO CONTINUE TO BE ALIGNED WITH THE U.S. AND SAUDI ARABIA
2018-07-20 20:29:50
0m
S&P SAYS RUSSIA 'BBB-/A-3' RATINGS AFFIRMED; OUTLOOK STABLE
2018-07-20 20:29:36
0m
S&P, ON KUWAIT, SAYS EXPECT RISING OIL PRODUCTION FROM THE SECOND HALF OF 2018
2018-07-20 20:29:30
0m
S&P SAYS EXPECT STRENGTHS IN KUWAIT'S PUBLIC & EXTERNAL BALANCE SHEETS TO OFFSET RISKS RELATED TO VOLATILE OIL PRICES, RISING GEOPOLITICAL TENSIONS IN THE REGION
2018-07-20 20:29:03
0m
FITCH, ON FRANCE, SAYS PUBLIC FINANCES, ALTHOUGH GRADUALLY IMPROVING, REMAIN A RATING WEAKNESS RELATIVE TO 'AA' CATEGORY
2018-07-20 20:28:42
0m
FITCH SAYS HAS REVISED OUTLOOK ON AUSTRIA'S LONG-TERM FOREIGN-CURRENCY ISSUER DEFAULT RATING TO POSITIVE FROM STABLE
2018-07-20 20:03:32
0m
FOR THE WEEK, THE S&P ROSE 0.02 PCT, THE DOW ADDED 0.15 PCT, THE NASDAQ SHED 0.07 PCT
2018-07-20 20:03:18
0m
BRAZIL'S BOVESPA CLOSED AT 78,476.69, UP +1.28%
2018-07-20 20:03:17
0m
BRAZIL'S BOVESPA CLOSED AT 78,476.69, UP +1.28%
2018-07-20 20:02:36
0m
CANADA'S S&P/TSX COMPOSITE CLOSED AT 16,418.25, DOWN -0.75%
2018-07-20 20:01:12
0m
NASDAQ UNOFFICIALLY CLOSES DOWN 5.97 POINTS, OR 0.08 PERCENT, AT 7,819.33
2018-07-20 20:00:29
0m
S&P 500 UNOFFICIALLY CLOSES DOWN 2.59 POINTS, OR 0.09 PERCENT, AT 2,801.90
2018-07-20 20:00:24
0m
DOW JONES UNOFFICIALLY CLOSES DOWN 7.50 POINTS, OR 0.03 PERCENT, AT 25,057.00
2018-07-20 19:25:13
0m
CFTC-SPECULATORS INCREASE CBOT US 5-YEAR TREASURY FUTURES NET SHORT POSITION BY 97,764 CONTRACTS TO 698,955 IN WEEK ON JULY 17
2018-07-20 19:25:07
0m
CFTC-SPECULATORS INCREASE CBOT US 10-YEAR TREASURY FUTURES NET SHORT POSITION BY 29,990 CONTRACTS TO 469,138 IN WEEK ON JULY 17
Most Popular
1

FxWirePro: GBP/JPY trade idea

2

FxWirePro: EUR/USD recovers more than 100 pips on Donald Trump comments on Fed, good to sell on rallies

3

FxWirePro: Copper extends rout, breaks new supports every week, next major bear target at 200W SMA

4

JP Morgan banks on blockchain technology with a patent, Investment bank giant to host IPOs in ICO pattern

5

BBVA signs €100M corporate loan with ACS using blockchain

6

FxWirePro: GBP/USD recovers after Donald Trump criticise fed rate hike, good to sell on rallies    

7

Fundamental Evaluation Series: AUD/USD vs. 2-year yield spread

8

America's Roundup: Dollar drops further on Trump's comments on currency, rate hike, U.S. stocks ends flat, Gold snaps losing run, Oil prices rise as concerns about oversupply ease-July 21st, 2018

9

U.S. Treasuries flat in muted session; Trump’s comments over Fed drag yields lower overnight

10

Fundamental Evaluation Series: USDJPY vs. 2-year yield spread

Economics Monitor

July 20 19:00 UTC Released

USCattle Placed On Fd

Actual

101 %

Forecast

Previous

July 20 19:00 UTC Released

USCattle On Feed

Actual

104 %

Forecast

Previous

January 31 00:00 UTC 248307248307m

ARAnnual Primary Balance*

Actual

Forecast

2016 bln ARS

Previous

Bln AR bln ARS

January 31 00:00 UTC 248307248307m

ARAnnual Primary Balance*

Actual

Forecast

2016 bln ARS

Previous

Bln AR bln ARS

January 22 19:00 UTC 260127260127m

ARTrade Balance

Actual

Forecast

Previous

-1541 %

January 31 00:00 UTC 248307248307m

ARAnnual Primary Balance*

Actual

Forecast

2016 bln ARS

Previous

Bln AR bln ARS

January 22 19:00 UTC 260127260127m

ARTrade Balance

Actual

Forecast

Previous

-1541 %

January 31 00:00 UTC 248307248307m

ARAnnual Primary Balance*

Actual

Forecast

2016 bln ARS

Previous

Bln AR bln ARS

January 31 00:00 UTC 248307248307m

ARAnnual Primary Balance*

Actual

Forecast

2016 bln ARS

Previous

Bln AR bln ARS

January 31 00:00 UTC 248307248307m

ARAnnual Primary Balance*

Actual

Forecast

2016 bln ARS

Previous

Bln AR bln ARS

EconoTimes
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.